News

Primary Hyperparathyroidism May Be Misdiagnosed

Publish date: March 13, 2012

 

FROM THE ANNUAL MEETING OF THE CENTRAL SURGICAL ASSOCIATION

Dr. Iannuzzi and his coauthors reported no relevant financial disclosures.

Pages

Recommended Reading

FDA Panel Endorses Obesity Drug Qnexa After All
MDedge Internal Medicine
Novel FFAR1 Agonist Shows Promise for Type 2 Diabetes
MDedge Internal Medicine
Memory Changes, Hyperglycemia Prompt Statin Label Changes
MDedge Internal Medicine
Pegvisomant Looks Safe for Long-Term Acromegaly Treatment
MDedge Internal Medicine
Pasireotide Slashes Cortisol Levels in Cushing's Disease
MDedge Internal Medicine
Long-Acting Opioids May Trigger Hypogonadism
MDedge Internal Medicine
Low PTH Levels Linked to Fracture Risk in Diabetic Women
MDedge Internal Medicine
Obesity Gives Independent Weight to Psoriatic Arthritis Risk
MDedge Internal Medicine
Duodenal Switch May Excel at Type 2 Diabetes Resolution
MDedge Internal Medicine
Slight Hyperglycemia Risk Shouldn't Deter Statin Use
MDedge Internal Medicine